Cargando…

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

BACKGROUND: In breast cancer, high levels of the inflammatory cytokine interleukin-6 (IL-6) have been associated with disease-free survival and treatment resistance. Increased serum levels of IL-6 have been correlated with increased levels of NF-κβ and aromatase expression in adipose tissue. Several...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markkula, Andrea, Simonsson, Maria, Ingvar, Christian, Rose, Carsten, Jernström, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198733/ https://www.ncbi.nlm.nih.gov/pubmed/25305747 http://dx.doi.org/10.1186/1471-2407-14-759

Ejemplares similares

Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
por: Markkula, Andrea, et al.
Publicado: (2014)

Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
por: Persson, Mia, et al.
Publicado: (2016)

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
por: Simonsson, Maria, et al.
Publicado: (2016)

Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events
por: Simonsson, Maria, et al.
Publicado: (2014)

Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events
por: Gustbée, Emma, et al.
Publicado: (2013)

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
por: Tryggvadottir, Helga, et al.
Publicado: (2018)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
por: Gustbée, Emma, et al.
Publicado: (2015)

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
por: Wisse, Agatha, et al.
Publicado: (2018)

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment
por: Björner, Sofie, et al.
Publicado: (2018)

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients
por: Lundin, K B, et al.
Publicado: (2011)

CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients
por: Jernström, H, et al.
Publicado: (2009)

Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women
por: Bågeman, E, et al.
Publicado: (2007)

Tumour Incidence and Tumour-Free Sublines in BR6 Mice
por: Mundy, J., et al.
Publicado: (1961)

The role of sex genotype in paediatric CNS tumour incidence and survival
por: Soon, Wai Cheong, et al.
Publicado: (2021)

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
por: Godina, Christopher, et al.
Publicado: (2023)

IL-6 Activities in the Tumour Microenvironment. Part 1
por: Chonov, Dimitur Chavdarov, et al.
Publicado: (2019)

IL‐6 mediates ER expansion during hyperpolarization of alternatively activated macrophages
por: Ayaub, Ehab A, et al.
Publicado: (2018)

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
por: Elebro, Karin, et al.
Publicado: (2017)

IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
por: Rose-John, Stefan
Publicado: (2012)

High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival
por: Mahmoodi, Ardalan, et al.
Publicado: (2022)

Targeting IL-6 trans-signalling: past, present and future prospects
por: Rose-John, Stefan, et al.
Publicado: (2023)

The relationship between IL-6 and thrombocytosis accompanying gastrointestinal tumours
por: Jósa, Valéria, et al.
Publicado: (2020)

Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma
por: Chen, Lih-Chyang, et al.
Publicado: (2012)

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
por: Gong, Yitao, et al.
Publicado: (2020)

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy
por: Mulder, Tessa A. M., et al.
Publicado: (2021)

Interleukin-6 (IL-6) serum concentrations in dogs with hepatitis and hepatic tumours compared with those with extra-hepatic inflammation and tumours
por: Neumann, Stephan, et al.
Publicado: (2010)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021)

Impact of tumour volume on prediction of progression-free survival in sinonasal cancer
por: Hennersdorf, Florian, et al.
Publicado: (2015)

The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours
por: Gudmundsdóttir, K, et al.
Publicado: (2000)

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19
por: Garbers, Christoph, et al.
Publicado: (2021)

Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer
por: Jernström, H, et al.
Publicado: (2008)

Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
por: Bai, Kaixuan, et al.
Publicado: (2023)

Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
por: Jayatilaka, Hasini, et al.
Publicado: (2017)

Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours
por: Martinez, Victor D., et al.
Publicado: (2018)

Hypothesis‐free deep survival learning applied to the tumour microenvironment in gastric cancer
por: Meier, Armin, et al.
Publicado: (2020)

Comparative Phenotypic and Genotypic Analysis of Swiss and Finnish Listeria monocytogenes Isolates with Respect to Benzalkonium Chloride Resistance
por: Meier, Anja B., et al.
Publicado: (2017)

Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
por: Cai, Zongye, et al.
Publicado: (2022)

Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
por: Sandén, Emma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q787j23i5ft9tbf6g3nv1nhe3q